BioMarin Pharmaceutical, Inc. (BMRN)
66.53
+0.10
(+0.15%)
USD |
NASDAQ |
Sep 04, 16:00
66.52
-0.01
(-0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical SG&A Expense (TTM) : 1.368B for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.368B |
| March 31, 2026 | 1.205B |
| December 31, 2025 | 1.153B |
| September 30, 2025 | 973.41M |
| June 30, 2025 | 958.51M |
| March 31, 2025 | 989.21M |
| December 31, 2024 | 1.009B |
| September 30, 2024 | 1.017B |
| June 30, 2024 | 987.85M |
| March 31, 2024 | 940.19M |
| December 31, 2023 | 937.29M |
| September 30, 2023 | 908.01M |
| June 30, 2023 | 900.89M |
| March 31, 2023 | 882.39M |
| December 31, 2022 | 854.01M |
| September 30, 2022 | 825.83M |
| June 30, 2022 | 792.35M |
| March 31, 2022 | 779.68M |
| December 31, 2021 | 759.38M |
| September 30, 2021 | 737.32M |
| June 30, 2021 | 733.44M |
| March 31, 2021 | 724.69M |
| December 31, 2020 | 737.67M |
| September 30, 2020 | 730.06M |
| June 30, 2020 | 720.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 706.06M |
| December 31, 2019 | 680.92M |
| September 30, 2019 | 657.20M |
| June 30, 2019 | 635.65M |
| March 31, 2019 | 628.18M |
| December 31, 2018 | 604.35M |
| September 30, 2018 | 600.46M |
| June 30, 2018 | 582.43M |
| March 31, 2018 | 572.65M |
| December 31, 2017 | 554.34M |
| September 30, 2017 | 537.01M |
| June 30, 2017 | 582.74M |
| March 31, 2017 | 598.51M |
| December 31, 2016 | 635.39M |
| September 30, 2016 | 606.34M |
| June 30, 2016 | 524.13M |
| March 31, 2016 | 466.36M |
| December 31, 2015 | 402.27M |
| September 30, 2015 | 388.13M |
| June 30, 2015 | 368.69M |
| March 31, 2015 | 335.27M |
| December 31, 2014 | 302.53M |
| September 30, 2014 | 274.57M |
| June 30, 2014 | 261.81M |
| March 31, 2014 | 244.38M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.318B |
| Vertex Pharmaceuticals, Inc. | 2.008B |
| BridgeBio Pharma, Inc. | 645.86M |
| Incyte Corp. | 1.399B |
| Ionis Pharmaceuticals, Inc. | 527.56M |